Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Irene Zacheo
Observed names:
I. Zacheo,
Irene Zaccheo
Institution:
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
Observed institutions:
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori,
Federico II University Hospital,
University of Naples Federico II,
Sapienza University of Rome
ORCID:
0000-0002-1603-8930
Observed ORCID:
0000-0002-1603-8930
OpenAlex ID:
A5089996507
Application of systematic coronary risk evaluation chart to identify chronic myeloid leukemia patients at risk of cardiovascular diseases during nilotinib treatment
2014
·
Massimo Breccia
, Matteo Molica
, et al.
·
Annals of Hematology
·
67
A Frontline Approach With Peripherally Inserted Versus Centrally Inserted Central Venous Catheters for Remission Induction Chemotherapy Phase of Acute Myeloid Leukemia: A Randomized Comparison
2018
·
Marco Picardi
, Roberta Della Pepa
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
46
Venetoclax and hypomethylating agents in octogenarians and nonagenarians with acute myeloid leukemia
2024
·
Ellen Madarang
, Jillian Lykon
, et al.
·
Blood Neoplasia
·
25
Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease
2023
·
Sabine Kayser
, Chiara Sartor
, et al.
·
Haematologica
·
25
PDF
Long‐term outcome of chronic myeloid leukaemia patients with p210 and p190 co‐expression at baseline
2014
·
Matteo Molica
, Irene Zacheo
, et al.
·
British Journal of Haematology
·
25
Disappearance of fibrosis in secondary myelofibrosis after ruxolitinib treatment: new endpoint to achieve?
2014
·
Matteo Molica
, Alessandra Serrao
, et al.
·
Annals of Hematology
·
25
The EUTOS score identifies chronic myeloid leukeamia patients with poor prognosis treated with imatinib first or second line
2012
·
Massimo Breccia
, Paola Finsinger
, et al.
·
Leukemia Research
·
25
Tenofovir vs lamivudine for the prevention of hepatitis B virus reactivation in advanced-stage DLBCL
2018
·
Marco Picardi
, Roberta Della Pepa
, et al.
·
Blood
·
24
PDF
Incidence of persistent/late chronic anemia in newly diagnosed patients with chronic myeloid leukemia responsive to imatinib
2014
·
Roberto Latagliata
, Paola Volpicelli
, et al.
·
American Journal of Hematology
·
14
PDF
Prognostic risk integration for survival modeling (PRISM) in newly diagnosed acute myeloid leukemia treated with venetoclax: a multinational retrospective cohort study
2025
·
Curtis Lachowiez
, Andy Kaempf
, et al.
·
Blood
·
10
Novel insights and therapeutic approaches in secondary AML
2024
·
Giovanni Marconi
, Michela Rondoni
, et al.
·
Frontiers in Oncology
·
10
PDF
Imatinib induces body mass changes in women with chronic myeloid leukemia
2013
·
Massimo Breccia
, Adriano Salaroli
, et al.
·
Annals of Hematology
·
10
Uncovering the expression of circPVT1 in the extracellular vesicles of acute myeloid leukemia patients
2023
·
Martina Ghetti
, Ivan Vannini
, et al.
·
Biomedicine & Pharmacotherapy
·
8
PDF
Dasatinib combined with weekly administration of vincristine as effective therapy in sudden or resistant Ph+ lymphoid blast crisis of chronic myeloid leukaemia
2012
·
Massimo Breccia
, Alessandra Serrao
, et al.
·
British Journal of Haematology
·
8
Correlation between Charlson comorbidity index and outcome in patients with chronic phase chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors upfront
2014
·
Massimo Breccia
, Matteo Molica
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
7
Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model
2026
·
Curtis A. Lachowiez
, Joshua F. Zeidner
, et al.
·
Journal of Clinical Oncology
·
6
PDF
(1-3)-β-d-Glucan serum increase and small-airway-invasive radiological findings as early signs of pulmonary aspergillosis in high-risk hematologic patients in the posaconazole era: preliminary observations
2018
·
M. Picardi
, R. Della Pepa
, et al.
·
Annals of Hematology
·
6
Low WT1 Expression Identifies a Subset of Acute Myeloid Leukemia with a Distinct Genotype
2025
·
Michela Rondoni
, Giovanni Marconi
, et al.
·
Cancers
·
5
PDF
Azacitidine followed by radiotherapy as effective treatment for chronic myelomonocytic leukemia with extramedullary localization
2012
·
Alessandra Serrao
, Giuseppina Loglisci
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
5
Unveiling Cryptic BCR-ABL1 Rearrangements: Diagnostic Challenges and Clinical Impact in Myeloid Malignancies
2025
·
Anna Ferrari
, Chiara Salvesi
, et al.
·
International Journal of Molecular Sciences
·
4
PDF
Rituximab in a risk‐adapted treatment strategy gives excellent therapeutic results in nodular lymphocyte‐predominant Hodgkin lymphoma
2017
·
Roberta Della Pepa
, Marco Picardi
, et al.
·
British Journal of Haematology
·
4
Azacitidine for myelodysplastic patients aged > 65 years: a review of clinical efficacy
2014
·
Massimo Breccia
, Matteo Molica
, et al.
·
Expert Opinion on Pharmacotherapy
·
4
Safety and comfort of domestic bortezomib injection in real-life experience
2018
·
Claudio Cerchione
, Davide Nappi
, et al.
·
Supportive Care in Cancer
·
3
A case of efficacy of bendamustine in heavily pretreated multiple myeloma, refractory to pomalidomide
2017
·
Claudio Cerchione
, Davide Nappi
, et al.
·
Clinical Case Reports
·
3
PDF
Novel Mechanisms of Venetoclax Resistance in Acute Myeloid Leukemia Based on Genomic Rearrangements
2023
·
Irene Zacheo
, Anna Ferrari
, et al.
·
Blood
·
2
Show more works
View as search
Works count:
42
Citation count:
378
H-index:
10
I10-index:
12
Year
Topic
Type